[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369817-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369817-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mapping-cancer-heterogeneity-a-consensus-network-approach-to-subtypes-and-pathways","Mapping cancer heterogeneity: a consensus network approach to subtypes and pathways","","Consensus MSClustering is presented as an unsupervised hierarchical network method that integrates multi-omics data to define molecular cancer subtypes and conserved pathways. A heterogeneity index is used to select 167 functionally coherent key genes, validated via Gene Ontology. Across 2439 tumors from 10 cancer types and an expanded set of 2675 tumors from 12 types with incomplete molecular data, the approach achieves accurate tumor classification, reveals pan-cancer squamous metaplastic signatures, and provides strong prognostic stratification with log-rank P=2.3×10−46.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mapping-cancer-heterogeneity-a-consensus-network-approach-to-subtypes-and-pathways/369817/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mapping-cancer-heterogeneity-a-consensus-network-approach-to-subtypes-and-pathways/369817.png","ImageObject",300,407,{"name":42,"@type":43},"Aran","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is MSClustering and what does it accomplish?","Question",{"text":63,"@type":64},"MSClustering is an unsupervised hierarchical network approach that integrates multi-omics data to identify molecular subtypes and conserved pathways across diverse cancers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the key genes selected and validated?",{"text":68,"@type":64},"A heterogeneity index selected 167 key genes, and their functional coherence was validated using Gene Ontology analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supports the method’s performance?",{"text":72,"@type":64},"Applied to 2439 tumors (10 cancer types) and extended to 2675 tumors (12 types), it enables precise classification and strong prognostic stratification (log-rank P=2.3×10−46), outperforming existing methods in accuracy, robustness, and computational efficiency.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369817,1790717902,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Briefings in Bioinformatics, 2025, 26(5), bbaf452  \n[https://doi.org/10.1093/bib/bbaf452](https://doi.org/10.1093/bib/bbaf452)  \nCase Study  \nMapping cancer heterogeneity: a consensus network approach to subtypes and pathways  \nGeng-Ming Hu, Hsin-Wei Chen, Chi-Ming Chen *  \nDepartment of Physics, National Taiwan Normal University, 88 Sec.4 Ting-Chou Rd., Taipei 116, Taiwan  \n*Corresponding author. Department of Physics, National Taiwan Normal University, 88 Sec.4 Ting-Chou Rd. , Taipei 116, Taiwan. Email: [cchen@phy.ntnu.edu.tw](cchen@phy.ntnu.edu.tw)  \nAbstract  \nWe introduce consensus MSClustering, an unsupervised hierarchical network approach that integrates multi-omics data to identify molecular subtypes and conserved pathways across diverse cancers. Using a novel heterogeneity index, we selected 167 key genes with functionally coherent roles validated through Gene Ontology analysis. Applied to 2439 tumors spanning 10 cancer types—and successfully extended to 2675 tumors (12 types) including cases with incomplete molecular data—MSClustering demonstrated:(i) precise classification of major cancer types and breast cancer molecular subtypes; (ii) discovery of novel pan-cancer squamous metaplastic signatures; (iii) exceptional prognostic stratification (log-rank P= 2.3 × 10−46); and (iv) superior performance over existing methods (COCA/SNF) in classification accuracy, cluster robustness, and computational efficiency. The method’s multi-scale architecture uniquely resolves breast cancer heterogeneity across biological resolution levels. Pathway analysis further revealed four key oncogenic programs—proteoglycan signaling, chromosomal stability, VEGF-mediated angiogenesis, and drug metabolism—along with disruptionsin immune and digestive system functions. This integrative framework marks a significant advancement in cancer genomics by enabling more refined molecular classification, enhanced prognostic insights, and deeper understanding of disease mechanisms. These results highlight the potential of MSClustering to inform the development of clinically relevant biomarkers and support more personalized strategies in precision oncology.  \nKeywords: heterogeneity; key genes; consensus clustering; unsupervised learning; enriched pathway network; cross-platform analysis  \nIntroduction  \nCancer is characterized by uncontrolled cell growth and abnormal division, creating a complex landscape of diseases. This complexity arises from various underlying factors, making an accurate classification essential for effective diagnosis, treatment planning, and prognosis. Traditionally, cancers have been categorized based on the tissue or cell type of origin and their microscopic characteristics. For instance, carcinomas develop from epithelial cells, sarcomas from connective tissues, leukemias from bloodforming cells, and lymphomas from the lymphatic system. While this histological classification provides a basic understanding, it has limitations for guiding treatment decisions and predicting patient outcomes [1] . As a result, the current WHO classification system recognizes the growing significance of molecular and genetic factors in identifying and classifying tumors [2] .  \nThe inherent difficulty in classifying cancer solely by its origin has driven research toward using global gene expression profiles to define tumor subtypes [3] . Perou et al. showed that breast cancer can be divided into distinct molecular subtypes based on gene expression [4], a finding later applied to many other cancers. Recent large-scale genomics projects have generated detailed molecular characterizations of thousands of tumors, paving the way for a systematic, molecular-based taxonomy of cancer [5 , 6] . This new approach addresses two key challenges: (1) class pre-  \ndiction, which involves assigning tumor samples to established categories, and (2) class discovery, which aims to identify previously unrecognized subtypes based on molecular signatures. Both strategies ","cbCaik4UWZgYncjZ","https://ap.wps.com/l/cbCaik4UWZgYncjZ","pdf",1415301,13,"English","# Abstract\n# Introduction","[{\"question\":\"What is MSClustering and what does it accomplish?\",\"answer\":\"MSClustering is an unsupervised hierarchical network approach that integrates multi-omics data to identify molecular subtypes and conserved pathways across diverse cancers.\"},{\"question\":\"How were the key genes selected and validated?\",\"answer\":\"A heterogeneity index selected 167 key genes, and their functional coherence was validated using Gene Ontology analysis.\"},{\"question\":\"What evidence supports the method’s performance?\",\"answer\":\"Applied to 2439 tumors (10 cancer types) and extended to 2675 tumors (12 types), it enables precise classification and strong prognostic stratification (log-rank P=2.3×10−46), outperforming existing methods in accuracy, robustness, and computational efficiency.\"}]","Mapping cancer heterogeneity: a consensus network approach to subtypes and pathways | PDF",1790184742,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e31534220d0a1f7c3f0fd093846e38c.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72fc7dfd49d82a9b45a45f6c94ac4e59.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6964db465f8ae399a68e9d0f51125e88.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff89783600713fbde49d3ea1281c657f.webp",980,1287]